Member Info for LostAllMyShirts

https://newswire.iguana2.com/af5f4d73c1a54a33/fme.asx/6A1101205/FME_High_grade_Ni-Cu-PGE_sulphides_confirmed_at_Panton

Future Metals pinpoints sulphide-rich targets outside mineral resource at Panton PGM Project
“Following these surveys, the company intends to test each respective target with diamond drilling and down-hole electromagnetics. These exploration activities offer significant upside to what is an already compelling high-grade, large PGM project," said MD and CEO Jardee Kininmonth.

Just wondering if anyone knows WHY the wholesale selling of so many shares ?. Started trying to work out the Buys versus the Sells, but became painfully clear that the Sells won hands down today. Is there any news they could have ?

Well it is starting to move now, 2 years later.

Is "Eh" a company symbol ?

Hello

Maybe someone can enlighten me as to whether it is better (Cheaper in spread and fees) to purchase Australian shares direct on ASX , or via LSE ?. Reason I ask is that I am not exactly happy to find that when I buy via Interactive Investor it costs me £108 sterling to buy £1,750 sterling of shares, plus £8 commission. See below copy of trade;

Stock Name
FUTURE METALS NL ORD NPV (DI)
Action
Buy
Order Type
Limit
Symbol
FME
Quantity
19,312.00
Limit Price
£0.095
Price
£0.0902
Consideration
£1,741.94
Commission
£7.99
Stamp Duty
£0.00
Levy
£0.00
Total
£1,749.93
Accrued Interest
AU$0.00
Expiry Date
21/06/22
Settlement Date
23/06/22

Thank you for the notes very interesting.

Infact I was just looking at the Chart for GILEAD SCIENCES and see that back in 1996 its price was about 75 Cents. Fast forward 25 years and it is now around 70 dollars having gone through a peak of 114 about 7 years ago. So take 1996 and 2014 and that means 10,000 invested in 1996 would have been be worth say 1.14 Million. So if you are patient you can see the returns.

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.
Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution toda

Any ideas who the US Biotech is ?. I know is confidential but probably will leak out ?. I know Pfizer tied up with a very small company called Voyager yesterday and Pfizer are on buying spree .

Does anyone know wbhy the price is going down ?. I though FAB was doing well ?

Yourgene Health (YGEN) Today's price 14.55 (0.3)
== BRIEF-MyHealthChecked Plc Says Agreement With Boots For COVID-19 Sample

Does anyone know why exactly the price dropped nearly 9% today ? Something must have happened.

I see there is a cap of £2M on the Royalties. Cannot understand why Nuformix would agree to such a Cap, as the potential for such drug is vast and they are limiting themselves to £2M, or am I missing something ?

Does anyone know what exactly the collaboration entails, financially ?. i.e. what will FAB get from any deal ?.

In a spreadsheet on the web Aqualung Therapeutics Corporation is developing ALT-100, a therapeutic monoclonal antibody, to combat serious unchecked inflammation. The initial application aims to reduce the mortality of Acute Respiratory Distress Syndrome (ARDS) and Ventilator-Induced Lung Injury (VILI). This offers a potential option in the treatment of COVID-19, which causes severe pneumonia and respiratory failure and can be compounded by mechanical ventilation, resulting in multi-organ failure and death. Aqualung Therapeutics has worked collaboratively with Fusion Antibodies to develop a superior therapeutic antibody. Aqualung’s ALT-100 antibody is a revolutionary, next generation antibody therapy. The humanized antibody has been developed and optimized by Fusion Antibodies’ revolutionary CDRx humanization and ADD developability platforms. "

following a share purchase on 11 February 2021

Paul Warwick holds 814,080 ordinary shares in the Company, representing 3.2 per cent. of the Company's issued share capital.

Richard Buick, Chief Technical Officer of the Company, has today sold 8,875 ordinary shares in the Company ("Ordinary Shares") a price of 124.2 pence per Ordinary Share. Following this sale, Richard Buick holds 486,250 Ordinary Shares,